Researchers linked higher weight loss after initiating antiobesity meds to lower risk for revision of hip and knee replacement.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Researchers found an association between higher adherence to the Mediterranean diet and a modest reduction in the risk for obesity-related cancers.

The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, to: Reduce the risk of major cardiovascular ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

The FDA has granted Priority Review to the BLA for deramiocel (CAP-1002) for the treatment of Duchenne muscular dystrophy cardiomyopathy.

A study has found that in patients with ischemic heart disease receiving ventricular tachycardia ablation there is higher risk of mortality.

A discussion of the link between hearing loss and cardiovascular disease with Paul Mick, MD, and Anil K Lalwani, MD.

A scientific statement regarding clinical considerations for athletes with cardiovascular abnormalities has been published by the AHA and ACC.

Wearable equipment-based telemedical management via multiparameter monitoring can help improve management in older patients with coronary heart disease.